Published 26 Jun, 2024

The proportion of women screened through BreastScreen Australia is a key performance indicator for the national breast screening program. Early detection can lead to better treatment options and improved chances of survival for women screened in the BreastScreen Program.1

    Charts

    Breast cancer is expected to be the most common cancer recorded in Australian Cancer Registries for females in 2023, with an age-standardised rate (age standardised to 2023 Australian population) projected at 149.9 per 100.000 females.2 It is estimated that in 2022, 20,428 females and 212 males were diagnosed with this disease, such that breast cancer comprised about 12.7% of all new cancer cases recorded in cancer registries and diagnosed in 2022. In addition, it is estimated that there were 3,214 deaths from breast cancer in 2022 (36 males and 3,178 females). These data indicate that a person has a 1 in 105 (or 0.95%) risk of dying from breast cancer by the age of 85 years (1 in 4,732 or 0.02% for males and 1 in 53 or 1.9% for females).3

    Breast screening aims to reduce mortality and morbidity from breast cancer by detecting asymptomatic breast cancers in females, enabling intervention at an early stage and increasing the likelihood of higher survival.Australian governments have made early detection of breast cancer a priority, with the BreastScreen Australia program receiving funding support from Commonwealth and state/territory governments since 1991. The Australian program was previously named the National Program for the Early Detection of Breast Cancer. The Program is free of charge and has provided biennial cancer screening for females aged 50–69 years, with the Federal Budget in 2013-14 allowing extension of the program to also actively invite females aged 70–74 years.1

    Services accredited by BreastScreen Australia operated according to the National Accreditation Standards (NAS) of BreastScreen Australia, along with the specified national policy features and protocols. BreastScreen Australia has been monitored since 1996–1997 using key performance indicators developed and endorsed by the former National Screening Information Advisory Group and by jurisdictional BreastScreen programs around: participation; rescreening; recall to assessment; invasive breast cancer detection; ductal carcinoma in situ detection; program sensitivity; incidence and mortality. 

    The Australian Institute of Health and Welfare (AIHW) reported that breast cancers detected through BreastScreen Australia had a 54% to 63% lower risk of causing death than breast cancers diagnosed in women who had never been screened through BreastScreen Australia.

    The overall BreastScreen participation by age is available up to 2021-2022 as a quarterly update, with the last report in July 2023,5 including the rate by Socioeconomic status and Remoteness and Indigenous status available up to 2020-2021 through the BreastScreen Monitoring report 2023.1 

    In the period 2021-2022, the estimated age-standardised participation rate of females aged 50–74 years and 50-69 years in the BreastScreen Australia program was correspondingly 49.6% and 49.2%.5

    The proportion (crude rate) of breast screen participation was the lowest in ages 50-54 years at 45.4% and reached 54.5% in females aged 65–69 years. The participation rate for ages 70–74 years was 52.0% which was similar to the participation rate of 52.1% for ages 60–64 years.5

     

    Aboriginal and Torres Strait Islander peoples

    In the period 2020–2021, the age-standardised participation for Indigenous females aged 50–74 years (34.9%) was lower than for their non-Indigenous counterparts (47.1%).1 Participation was highest in Indigenous females aged 65-69 years at 41.7%, followed by ages 70-74 years at 38.1%, and was lowest for ages 50-44 years at 29.3%.1 

     

    Remoteness and socioeconomic status (SES)

    In 2020–2021, the age-standardised participation of women aged 50–74 years was highest in Outer regional and Inner regional areas at 53.7% and 50.6%, respectively, followed by Remote areas (48.8%) and Major cities (45.0%). Participation was lowest for those living in Very remote areas at 37.1%.1

    There was little variation in participation for females aged 50–74 years across socioeconomic (SES) areas in 2020-2021. Participation among females aged 50–74 years varied marginally by SES area of residence, with the lowest (44.8%) applying to the most disadvantaged.1

    Participation is measured over 2 years to align with the 2-year recommended screening interval, as most participants will screen only once within a 2-year period. A consequence of measuring participation over 2 years on an annual basis is that there are ‘rolling’ participation rates, in which there is an overlap of 1 calendar year between any 2 consecutive rates. Because of this, the participation rate for a 2-year reporting period is often compared with the previous non-overlapping rate. Participation is based on the number of participants screened, not the number of screening mammograms performed.1

    Participation data are reported as a percentage of females in the population.

    The most recent participation data are for participants who had a screening mammogram in 2021 and 2022 (note: preliminary data from the most recent quarterly screening report.5)

    Data sources: 

     

    • Australian Institute of Health and Welfare 2023. Cancer screening programs: quarterly data. Cat. no. CAN 114. Canberra: AIHW. 
    • Australian Institute of Health and Welfare 2023. BreastScreen Australia monitoring report 2023. Cat. no. CAN 155. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2022. BreastScreen Australia monitoring report 2022. Cat. no. CAN 150. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2021. BreastScreen Australia monitoring report 2021. Cat. no. CAN 140. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2020. BreastScreen Australia monitoring report 2020. Cancer series no. 129. Cat. no. CAN 135. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2019. BreastScreen Australia monitoring report 2019. Cancer series no. 127. Cat. no. CAN 128. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2018. BreastScreen Australia monitoring report 2018. Cancer series no. 112. Cat. no. CAN 116. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2017. BreastScreen Australia monitoring report 2014–2015. Cancer series no. 106. Cat. no. CAN 105. Canberra: AIHW.
    • Australian Institute of Health and Welfare 2016. BreastScreen Australia monitoring report 2013–2014. Cancer series no. 100. Cat. no. CAN 99. Canberra: AIHW. 
    • Australian Institute of Health and Welfare 2015. BreastScreen Australia monitoring report 2012–2013. Cancer series no.95. Cat. no. CAN 93. Canberra: AIHW.

    Methodology:

    In the 2023 monitoring report, crude rates are the number of participants screened as a percentage of the eligible female population calculated as the average of the 2020 and 2021 Australian Bureau of Statistics estimated resident populations. Age-standardised rates are the number of participants screened as a percentage of the eligible female population calculated as the average of the 2020 and 2021 Australian Bureau of Statistics estimated resident populations and age standardised to the Australian population at 30 June 2001.1

    Population size is calculated as the average of the ABS estimated resident population at 30 June for the two years. Each 2-year period covers from 1 January in the first year to 31 December in the following year. For example, 2020–2021 covers 1 January 2020 to 31 December 2021 inclusive.1

    Indigenous status is self-reported; therefore, accuracy of Indigenous participation rates will be affected depending on whether participants choose to identify as Indigenous at the time of screening.1

    Remoteness

    The Australian Statistical Geography Standard (ASGS) for 2016 was used to classify participants by remoteness of usual residence.

    Socioeconomic status (SES)

    The Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) for 2016 was used to classify participants by SES quintile of usual residence. 

    Data:

    Australian Institute of Health and Welfare 2023. Cancer screening programs: quarterly data. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screening-programs-participation/data

    Australian Institute of Health and Welfare. Breastscreen Australia Monitoring Report. Report editions. Accessed May 2024;

    https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2023/report-editions

    Policy:

    Australia Government Department of Health. BreastScreen Australia Program – Evaluation of target age expansion – Final report. Accessed May 2024; https://www.health.gov.au/resources/publications/breastscreen-australia-program-evaluation-of-target-age-expansion-final-report?language=en

    Australia Government Department of Health. BreastScreen Australia Program. Accessed May 2024; https://www.health.gov.au/our-work/breastscreen-australia-program

     

    References

    1. Australian Institute of Health and Welfare 2023. BreastScreen Australia monitoring report 2023. Cat. no. CAN 155. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2023/summary
    2. Australian Institute of Health and Welfare 2022. Cancer Data in Australia. Cancer rankings data visualisation. Accessed May 2024; https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/cancer-rankings-data-visualisation
    3. Cancer Australia 2022. Breast cancer statistics. Cancer Australia 2022. Accessed May 2024; https://www.canceraustralia.gov.au/cancer-types/breast-cancer/statistics
    4. Australian Institute of Health and Welfare 2018. Analysis of breast cancer outcomes and screening behaviour for BreastScreen Australia. Cat. no. CAN 118. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/getmedia/80c7b90b-21aa-4f19-943d-c338f432076c/aihw-can-118.pdf.aspx?inline=true
    5. Australian Institute of Health and Welfare 2023. Cancer screening programs: quarterly data. Jul 23. Accessed May 24; https://www.aihw.gov.au/reports/cancer-screening/national-cancer-screening-programs-participation/contents/breastscreen-australia/breast-cancer-screening-participation
    6. Australian Institute of Health and Welfare 2022. BreastScreen Australia monitoring report 2022. Cat. no. CAN 150. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2022/summary
    7. Australian Institute of Health and Welfare 2021. BreastScreen Australia monitoring report 2021. Cat. no. CAN 140. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2021/summary
    8. Australian Institute of Health and Welfare 2020. BreastScreen Australia monitoring report 2020. Cat. no. CAN 135. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2020/summary
    9. Australian Institute of Health and Welfare 2019. BreastScreen Australia monitoring report 2019. Cat. no. CAN 128. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2019/summary
    10. Australian Institute of Health and Welfare 2018. BreastScreen Australia monitoring report 2015-16. Cat. no. CAN 116. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-report-2018/contents/summary
    11. Australian Institute of Health and Welfare 2017. BreastScreen Australia monitoring report 2014-15. Cat. no. CAN 105. Canberra: AIHW. Accessed May 2024; https://www.aihw.gov.au/reports/cancer-screening/breastscreen-australia-monitoring-2014-15/summary
    12. Australian Institute of Health and Welfare. Cancer data in Australia. Cancer incidence by age visualisation. Accessed May 2024; https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/cancer-incidence-by-age-visualisation
    13. Australian Institute of Health and Welfare. Cancer data in Australia. Cancer mortality by age visualisation. Accessed May 2024; https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/cancer-mortality-by-age-visualisation
    14. Australian Institute of Health and Welfare. Cancer data in Australia. Cancer survival data visualisation. Accessed May 2024;https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/contents/survival

    Summary

    Approximately half of eligible women participate in BreastScreen Australia during a 2-year period

    In 2021-2022, the estimated age-standardised participation rate of females aged 50–74 years and 50-69 years in the BreastScreen Australia program was correspondingly 49.6% and 49.2%. 49.2%.

    Breast screening participation is lower among Indigenous than non-Indigenous females

    In the 2020-2021 period, 34.9% Aboriginal and Torres Strait Islander women aged 50–74 years participated in Breast Screening compared with a corresponding 41.7% for non-Indigenous women. 

    Breast screening participation is lowest among females living in Very remote areas

    In the period 2020–2021, the age-standardised participation rate was lowest among females aged 50–74 years living in Very remote areas (37.1%).